Annual Accounts Receivable
N/A
December 31, 2021
Summary
- IDRA annual accounts receivable is not available.
Performance
IDRA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.96 M
NaN%
September 30, 2022
Summary
- As of February 10, 2025, IDRA quarterly accounts receivable is $1.96 million
Performance
IDRA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
IDRA Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
IDRA Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | ||
| 5 y | 5-year | at high | at low | ||
| alltime | all time | -54.2% | -93.6% |
Idera Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.96 M(+43.3%) |
| Sep 2008 | - | $1.37 M(+71.2%) |
| Jun 2008 | - | $801.00 K(+65.8%) |
| Mar 2008 | - | $483.00 K(-23.1%) |
| Dec 2007 | $628.00 K(+57.8%) | $628.00 K(+62.7%) |
| Sep 2007 | - | $386.00 K(-5.9%) |
| Jun 2007 | - | $410.00 K(-73.9%) |
| Mar 2007 | - | $1.57 M(+295.0%) |
| Dec 2006 | $398.00 K(+126.3%) | $398.00 K(+135.6%) |
| Sep 2006 | - | $168.90 K(+15.0%) |
| Jun 2006 | - | $146.90 K(-19.6%) |
| Mar 2006 | - | $182.70 K(+3.9%) |
| Dec 2005 | $175.90 K(-40.0%) | $175.90 K(+0.3%) |
| Sep 2005 | - | $175.30 K(-95.9%) |
| Jun 2005 | - | $4.28 M(+1950.0%) |
| Mar 2005 | - | $209.00 K(-28.7%) |
| Dec 2004 | $293.10 K | $293.10 K(+49.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2004 | - | $196.10 K(-26.1%) |
| Jun 2004 | - | $265.50 K(-60.1%) |
| Mar 2004 | - | $665.10 K(+227.8%) |
| Dec 2003 | $202.90 K(-50.1%) | $202.90 K(-1.6%) |
| Sep 2003 | - | $206.20 K(+64.6%) |
| Jun 2003 | - | $125.30 K(-36.3%) |
| Mar 2003 | - | $196.70 K(-51.6%) |
| Dec 2002 | $406.30 K(+47.8%) | $406.30 K(-26.3%) |
| Sep 2002 | - | $551.30 K(+79.2%) |
| Jun 2002 | - | $307.70 K(-61.5%) |
| Mar 2002 | - | $799.30 K(+190.8%) |
| Dec 2001 | $274.90 K(-18.5%) | $274.90 K(+41.4%) |
| Sep 2001 | - | $194.40 K(-84.0%) |
| Jun 2001 | - | $1.21 M(+63.7%) |
| Mar 2001 | - | $740.30 K(+119.4%) |
| Dec 2000 | $337.40 K(-71.3%) | $337.40 K |
| Dec 1998 | $1.18 M(+121.9%) | - |
| Dec 1997 | $529.70 K | - |
FAQ
- What is the all time high annual accounts receivable for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Idera Pharmaceuticals?
What is the all time high annual accounts receivable for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual accounts receivable is $1.18 M
What is Idera Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of IDRA is $1.96 M
What is the all time high quarterly accounts receivable for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly accounts receivable is $4.28 M